Skip to content

Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances
Study identifies nonmutational p53 dysfunction as MDS risk factor
FDA grants Orphan Drug designation for bexmarilimab in MDS
Triplet combination does not extend survival for patients with AML
Novel cell therapy approach shows ‘preliminary’ safety and efficacy in lymphoma

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Triplet combination does not extend survival for patients with AML

Cellular Therapy

Triplet combination does not extend survival for patients with AML

Leukemia

Triplet combination does not extend survival for patients with AML

Lymphoma

Triplet combination does not extend survival for patients with AML

Multiple Myeloma

Triplet combination does not extend survival for patients with AML

Myelodysplastic Syndromes

Triplet combination does not extend survival for patients with AML

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 14, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
Subscribe

SOHO Insider Hem/Onc Library Leukemia

Leukemia News

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Top Categories

Cellular Therapy

11

Leukemia

35

Lymphoma

34

Multiple Myeloma

27

Myelodysplastic Syndromes

13

Myeloproliferative Neoplasms

8

POPULAR NEWS

SOHO_Insider_Podcast-01[67]

Podcast

Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances

May 14, 2025

Organization structure, social network and teamwork concept on dark background. Business people icon on wooden cube blocks connecting network of connections.

Myelodysplastic Syndromes

Study identifies nonmutational p53 dysfunction as MDS risk factor

May 13, 2025

Green light

Myelodysplastic Syndromes

FDA grants Orphan Drug designation for bexmarilimab in MDS

May 12, 2025

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

Triplet combination does not extend survival for patients with AML

Cellular Therapy

Triplet combination does not extend survival for patients with AML

Leukemia

Triplet combination does not extend survival for patients with AML

Lymphoma

Triplet combination does not extend survival for patients with AML

Multiple Myeloma

Triplet combination does not extend survival for patients with AML

Myelodysplastic Syndromes

Triplet combination does not extend survival for patients with AML

Myeloproliferative Neoplasms

Subscribe

Recent Posts

SOHO_Insider_Podcast-01[67]

Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances

Organization structure, social network and teamwork concept on dark background. Business people icon on wooden cube blocks connecting network of connections.

Study identifies nonmutational p53 dysfunction as MDS risk factor

Green light

FDA grants Orphan Drug designation for bexmarilimab in MDS

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.